Sports nutrition brand Applied Nutrition’s revenue increased by 50 per cent year-on-year to £160m, compared to £107m in the year prior, which was well ahead of market expectations.

According to the business, the strong full-year results were driven by strong sustained demand across the group’s markets and channels.

The company’s net cash at the end of FY26 was £15.9m, after the acquisition of the trade and assets of Nutrablend and an increased working capital to support growth.

Applied Nutrition raised its full-year outlook for the upcoming financial year ending on 31 July 2027 based on overall strong consumer demand and better-than-expected results in FY26.

Subscribe to Grocery Gazette for free

Sign up here to get the latest grocery and food news each morning

Applied Nutrition now forecasted an adjusted EBITDA increase of 13 per cent year-on-year to approximately £49m from £42m in FY27.

Additionally, the business raised the outlook for its full-year revenue, which is expected to grow to around £205m ahead of previous guidance and current market expectations.

However, the company expects the FY27 EBITDA margin to decrease slightly due to a higher revenue contribution from the US alongside significantly higher whey protein costs globally.

This current performance follows significant investments from the business this year. Applied Nutrition acquired a US-based manufacturing facility in June as part of its push towards expanding its presence in North America.

Additionally, last month the brand launched a new GLP-1-friendly supplement range exclusively at Holland & Barrett as the demand grows for weight-loss drugs.